About Us
"LifeStrands", deriving from a combination of "Life" and DNA "Strands" that form the blueprint of lives. We believe everyone deserves access to better healthcare through the advancement of genomics.
Advancing Genomics For A Better World
Advancing Genomics For A Better World
The world of clinical genomics is one of unparalleled potential and promise.
By unlocking our genetic code, we have the power to revolutionise the way we diagnose and treat diseases and conditions, delivering genetic testing solutions that pave the way for more informed health decisions.
Precision medicine is at the core of everything we do. Through the knowledge of genomics, we aim to help clinicians and patients find meaning in their health by leveraging critical genetic information to make a difference.
Our highly trained and dedicated team of experts are committed to providing more accurate, safer and reliable actionable genomics test services that enable clinicians to deliver more personalised, patientcentric recommendations based on individual genetic profiles.
LifeStrands At A Snapshot
LifeStrands At A Snapshot
Founded in June 2020 as a genomics and life science subsidiary of Pathology Asia Group, headquartered in Singapore.
Certified as Nanostring GeoMx DSP, Twist Biosciences NGS Prolab and 10X Genomics Spatial Gene Expression Service Provider between October 2021 and May 2022.
Accredited with MOH HCSA Level 3 genetic testing, CAP and SAC-SINGLAS ISO 15189 (medical testing) accreditations within six months in 2022.
Our People
Pathology Asia Group MD/CEO
- Co-founder of Biomark and CEO of Innovative Diagnostics
- Founder of Quantum Diagnostics
- Former CEO of Quest Laboratories and Gribbles Pathology
- Previously Assistant Head (Biomedical Sciences Group) at the Economic Development Board of Singapore
- Member of Malaysia’s National Key Economic Area (NKEA) Healthcare initiative
- Over 18 years of corporate experience, including 8 years of Corporate Finance and Mergers & Acquisitions expertise
- Previously led EY Asia Pacific’s healthcare CF/M&A space
- Also served with PwC Singapore and UEM Group, a subsidiary of Khazanah Nasional
- More than 18 years of experience in the medical laboratory industry
- Spearheaded multiple quality initiatives, including CAP and ISO 15189 accreditation; and Westgard Verification
- Led and managed multiple mergers and laboratory rollouts
- With > 10 years experiences in clinical & diagnostic genomics
- NATA technical assessor for genomics & anatomical pathology
- Previous roles held:
- Medical Director, Dept. of Diagnostic Genomics at Monash Health
- Chief Molecular Pathologist at St. Vincent’s Hospital Melbourne
Dr. Hongdo Do
Laboratory Director
- Ph.D. awardee from Melbourne University in Cancer Genetics and Epigenetics Study
- Previous roles – Head Scientist (St. Vincent’s Hospital Melbourne), Quality manager (TGEG, NATA accredited lab), Research Associate (ONJCRI) and Postdoctoral fellows (ONJCRI, LICR & PMCC)
- 20 yrs. of experience in molecular diagnostics and research/development
- Experienced in ISO15189 and CAP audits
- With > 10 years experiences in clinical & diagnostic genomics
- NATA technical assessor for genomics & anatomical pathology
- Previous roles held:
- Medical Director, Dept. of Diagnostic Genomics at Monash Health
- Chief Molecular Pathologist at St. Vincent’s Hospital Melbourne